{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:50:21Z","timestamp":1792788621034,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T00:00:00Z","timestamp":1529625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1038\/s41380-018-0094-5","type":"journal-article","created":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T04:25:04Z","timestamp":1529641504000},"page":"1868-1883","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":316,"title":["Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"24","author":[{"given":"Jun","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1881-0939","authenticated-orcid":false,"given":"Yan-Ping","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru-Jia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Fan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo-Xuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Qiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Degenhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic C.","family":"Blow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Ilgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,22]]},"reference":[{"key":"94_CR1","volume-title":"World drug report","author":"United Nations Office on Drugs and Crime.","year":"2015","unstructured":"United Nations Office on Drugs and Crime. World drug report. Vienna: United Nations Office on Drugs and Crime; 2015."},{"key":"94_CR2","volume-title":"World drug report","author":"United Nations Office on Drugs and Crime.","year":"2016","unstructured":"United Nations Office on Drugs and Crime. World drug report. Vienna: United Nations Office on Drugs and Crime; 2016."},{"key":"94_CR3","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/S0140-6736(13)61530-5","volume":"382","author":"L Degenhardt","year":"2013","unstructured":"Degenhardt L, Whiteford HA, Ferrari AJ, Baxter AJ, Charlson FJ, Hall WD, et al. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382:1564\u201374.","journal-title":"Lancet"},{"key":"94_CR4","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1001\/jama.2017.13358","volume":"318","author":"LO Gostin","year":"2017","unstructured":"Gostin LO, Hodge JG Jr., Noe SA. Reframing the opioid epidemic as a national emergency. JAMA. 2017;318:1539\u201340.","journal-title":"JAMA"},{"key":"94_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","volume":"106","author":"L Degenhardt","year":"2011","unstructured":"Degenhardt L, Bucello C, Mathers B, Briegleb C, Ali H, Hickman M, et al. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction. 2011;106:32\u201351.","journal-title":"Addiction"},{"key":"94_CR6","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2016: trends and developments. Publications Office of the European Union, Luxembourg: European Monitoring Centre for Drugs and Drug Addiction; 2016."},{"key":"94_CR7","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1056\/NEJMp1402780","volume":"370","author":"ND Volkow","year":"2014","unstructured":"Volkow ND, Frieden TR, Hyde PS, Cha SS. Medication-assisted therapies\u2014tackling the opioid-overdose epidemic. N Engl J Med. 2014;370:2063\u20136.","journal-title":"N Engl J Med"},{"key":"94_CR8","doi-asserted-by":"crossref","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009; 3:CD002209.","DOI":"10.1002\/14651858.CD002209.pub2"},{"key":"94_CR9","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1001\/jama.2017.0001","volume":"317","author":"S Nielsen","year":"2017","unstructured":"Nielsen S, Larance B, Lintzeris N. Opioid agonist treatment for patients with dependence on prescription opioids. JAMA. 2017;317:967\u20138.","journal-title":"JAMA"},{"key":"94_CR10","doi-asserted-by":"publisher","first-page":"e5945","DOI":"10.1136\/bmj.e5945","volume":"345","author":"GJ MacArthur","year":"2012","unstructured":"MacArthur GJ, Minozzi S, Martin N, Vickerman P, Deren S, Bruneau J, et al. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ. 2012;345:e5945.","journal-title":"BMJ"},{"key":"94_CR11","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1111\/j.1360-0443.2011.03463.x","volume":"106","author":"J Reimer","year":"2011","unstructured":"Reimer J, Verthein U, Karow A, Schafer I, Naber D, Haasen C. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial. Addiction. 2011;106:1647\u201355.","journal-title":"Addiction"},{"key":"94_CR12","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1080\/14656566.2016.1244529","volume":"17","author":"D Ayanga","year":"2016","unstructured":"Ayanga D, Shorter D, Kosten TR. Update on pharmacotherapy for treatment of opioid use disorder. Expert Opin Pharmacother. 2016;17:2307\u201318.","journal-title":"Expert Opin Pharmacother"},{"key":"94_CR13","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/S0140-6736(11)60358-9","volume":"377","author":"E Krupitsky","year":"2011","unstructured":"Krupitsky E, Nunes EV, Ling W, Illeperuma A, Gastfriend DR, Silverman BL. Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial. Lancet. 2011;377:1506\u201313.","journal-title":"Lancet"},{"key":"94_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/add.13087","volume":"111","author":"G Cousins","year":"2016","unstructured":"Cousins G, Boland F, Courtney B, Barry J, Lyons S, Fahey T. Risk of mortality on and off methadone substitution treatment in primary care: a national cohort study. Addiction. 2016;111:73\u201382.","journal-title":"Addiction"},{"key":"94_CR15","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1111\/add.12863","volume":"110","author":"E Evans","year":"2015","unstructured":"Evans E, Li L, Min J, Huang D, Urada D, Liu L, et al. Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006-10. Addiction. 2015;110:996\u20131005.","journal-title":"Addiction"},{"key":"94_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1300\/J126v01n04_05","volume":"1","author":"DP Desmond","year":"2000","unstructured":"Desmond DP, Maddux JF. Deaths among heroin users in and out of methadone treatment. J Maint Addict. 2000;1:45\u201361.","journal-title":"J Maint Addict"},{"key":"94_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2471\/BLT.12.108282","volume":"91","author":"BM Mathers","year":"2013","unstructured":"Mathers BM, Degenhardt L, Bucello C, Lemon J, Wiessing L, Hickman M. Mortality among people who inject drugs: a systematic review and meta-analysis. Bull World Health Organ. 2013;91:102\u201323.","journal-title":"Bull World Health Organ"},{"key":"94_CR18","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/ije\/dyu018","volume":"43","author":"M Roerecke","year":"2014","unstructured":"Roerecke M, Rehm J. Cause-specific mortality risk in alcohol use disorder treatment patients: a systematic review and meta-analysis. Int J Epidemiol. 2014;43:906\u201319.","journal-title":"Int J Epidemiol"},{"key":"94_CR19","doi-asserted-by":"publisher","first-page":"c5475","DOI":"10.1136\/bmj.c5475","volume":"341","author":"R Cornish","year":"2010","unstructured":"Cornish R, Macleod J, Strang J, Vickerman P, Hickman M. Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database. BMJ. 2010;341:c5475.","journal-title":"BMJ"},{"key":"94_CR20","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S2215-0366(15)00366-1","volume":"2","author":"J Kimber","year":"2015","unstructured":"Kimber J, Larney S, Hickman M, Randall D, Degenhardt L. Mortality risk of opioid substitution therapy with methadone versus buprenorphine: a retrospective cohort study. Lancet Psychiatry. 2015;2:901\u20138.","journal-title":"Lancet Psychiatry"},{"key":"94_CR21","doi-asserted-by":"publisher","first-page":"j1550","DOI":"10.1136\/bmj.j1550","volume":"357","author":"L Sordo","year":"2017","unstructured":"Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550.","journal-title":"BMJ"},{"key":"94_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/ADM.0b013e318287cfc9","volume":"7","author":"E Peles","year":"2013","unstructured":"Peles E, Schreiber S, Adelson M. Opiate-dependent patients on a waiting list for methadone maintenance treatment are at high risk for mortality until treatment entry. J Addict Med. 2013;7:177\u201382.","journal-title":"J Addict Med"},{"key":"94_CR23","unstructured":"Bargagli AM, Davoli M, Minozzi S, Vecchi S, Perucci CA. A systematic review of observational studies on treatment of opioid dependence. Background document prepared for 3rd meeting of Technical Development Group (TDG) for the WHO Guidelines for Psychosocially Assisted Pharmacotherapy of Opiod Dependence. Geneva, Switzerland; 2007."},{"key":"94_CR24","doi-asserted-by":"publisher","first-page":"e82476","DOI":"10.1371\/journal.pone.0082476","volume":"8","author":"X Cao","year":"2013","unstructured":"Cao X, Wu Z, Li L, Pang L, Rou K, Wang C, et al. Mortality among methadone maintenance clients in China: a six-year cohort study. PLoS ONE. 2013;8:e82476.","journal-title":"PLoS ONE"},{"key":"94_CR25","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.jpsychires.2013.07.001","volume":"47","author":"DL Liao","year":"2013","unstructured":"Liao DL, Chen PC, Chen CH, Hsieh CJ, Huang YF, Shih WY, et al. Higher methadone doses are associated with lower mortality in patients of opioid dependence in Taiwan. J Psychiatr Res. 2013;47:1530\u20134.","journal-title":"J Psychiatr Res"},{"key":"94_CR26","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.","journal-title":"BMJ"},{"key":"94_CR27","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/cid\/civ476","volume":"61","author":"B Nosyk","year":"2015","unstructured":"Nosyk B, Min JE, Evans E, Li L, Liu L, Lima VD, et al. The effects of opioid substitution treatment and highly active antiretroviral therapy on the cause-specific risk of mortality among HIV-positive people who inject drugs. Clin Infect Dis. 2015;61:1157\u201365.","journal-title":"Clin Infect Dis"},{"key":"94_CR28","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/j.1360-0443.1995.tb02209.x","volume":"90","author":"A Fugelstad","year":"1995","unstructured":"Fugelstad A, Rajs J, B\u00f6ttiger M, Gerhardsson de Verdier M. Mortality among HIV-infected intravenous drug addicts in Stockholm in relation to methadone treatment. Addiction. 1995;90:711\u20136.","journal-title":"Addiction"},{"key":"94_CR29","first-page":"443","volume":"7","author":"J Fellows-Smith","year":"2011","unstructured":"Fellows-Smith J. Opioid-dependent error processing. J Opioid Manag. 2011;7:443\u20139.","journal-title":"J Opioid Manag"},{"key":"94_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1080\/10550880903435988","volume":"29","author":"AS Reece","year":"2010","unstructured":"Reece AS. Favorable mortality profile of naltrexone implants for opiate addiction. J Addict Dis. 2010;29:30\u201350.","journal-title":"J Addict Dis"},{"key":"94_CR31","unstructured":"Wells GA, Shea B, O\u2019 Connell D, Robertson J, Peterson J, Welch V et al. The Newcastle\u2013Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. \nhttp:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp\n\n. Accessed 12 Mar 2016."},{"key":"94_CR32","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.ctrv.2015.04.005","volume":"41","author":"S Zhong","year":"2015","unstructured":"Zhong S, Zhang X, Chen L, Ma T, Tang J, Zhao J. Statin use and mortality in cancer patients: Systematic review and meta-analysis of observational studies. Cancer Treat Rev. 2015;41:554\u201367.","journal-title":"Cancer Treat Rev"},{"key":"94_CR33","doi-asserted-by":"publisher","first-page":"S435","DOI":"10.1097\/QAD.0000000000000435","volume":"28","author":"BM Mathers","year":"2014","unstructured":"Mathers BM, Degenhardt L. Examining non-AIDS mortality among people who inject drugs. AIDS. 2014;28:S435\u201344.","journal-title":"AIDS"},{"key":"94_CR34","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088\u2013101.","journal-title":"Biometrics"},{"key":"94_CR35","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3109\/10826089609045806","volume":"31","author":"JR Caplehorn","year":"1996","unstructured":"Caplehorn JR, Dalton MS, Haldar F, Petrenas AM, Nisbet JG. Methadone maintenance and addicts\u2019 risk of fatal heroin overdose. Subst Use Misuse. 1996;31:177\u201396.","journal-title":"Subst Use Misuse"},{"key":"94_CR36","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.drugalcdep.2007.11.003","volume":"94","author":"T Clausen","year":"2008","unstructured":"Clausen T, Anchersen K, Waal H. Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study. Drug Alcohol Depend. 2008;94:151\u20137.","journal-title":"Drug Alcohol Depend"},{"key":"94_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.drugalcdep.2009.05.021","volume":"105","author":"L Degenhardt","year":"2009","unstructured":"Degenhardt L, Randall D, Hall W, Law M, Butler T, Burns L. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved. Drug Alcohol Depend. 2009;105:9\u201315.","journal-title":"Drug Alcohol Depend"},{"key":"94_CR38","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/j.1360-0443.2005.01089.x","volume":"100","author":"MT Brugal","year":"2005","unstructured":"Brugal MT, Domingo-Salvany A, Puig R, Barrio G, Garcia de Olalla P, de la Fuente L. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. Addiction. 2005;100:981\u20139.","journal-title":"Addiction"},{"key":"94_CR39","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/dar.12205","volume":"34","author":"L Degenhardt","year":"2015","unstructured":"Degenhardt L, Larney S, Kimber J, Farrell M, Hall W. Excess mortality among opioid-using patients treated with oral naltrexone in Australia. Drug Alcohol Rev. 2015;34:90\u20136.","journal-title":"Drug Alcohol Rev"},{"key":"94_CR40","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1360-0443.2006.01714.x","volume":"102","author":"A Fugelstad","year":"2007","unstructured":"Fugelstad A, Stenbacka M, Leifman A, Nylander M, Thiblin I. Methadone maintenance treatment: the balance between life-saving treatment and fatal poisonings. Addiction. 2007;102:406\u201312.","journal-title":"Addiction"},{"key":"94_CR41","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1600-0447.1990.tb03057.x","volume":"82","author":"L Gronbladh","year":"1990","unstructured":"Gronbladh L, Ohlund LS, Gunne LM. Mortality in heroin addiction: impact of methadone treatment. Acta Psychiatr Scand. 1990;82:223\u20137.","journal-title":"Acta Psychiatr Scand"},{"key":"94_CR42","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.drugalcdep.2015.05.033","volume":"153","author":"KC Chang","year":"2015","unstructured":"Chang KC, Lu TH, Lee KY, Hwang JS, Cheng CM, Wang JD. Estimation of life expectancy and the expected years of life lost among heroin users in the era of opioid substitution treatment (OST) in Taiwan. Drug Alcohol Depend. 2015;153:152\u20138.","journal-title":"Drug Alcohol Depend"},{"key":"94_CR43","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.drugalcdep.2009.09.013","volume":"107","author":"E Peles","year":"2010","unstructured":"Peles E, Schreiber S, Adelson M. 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel. Drug Alcohol Depend. 2010;107:141\u20138.","journal-title":"Drug Alcohol Depend"},{"key":"94_CR44","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3109\/00952997709007010","volume":"4","author":"P Cushman","year":"1977","unstructured":"Cushman P. Ten years of methadone maintenance treatment: some clinical observations. Am J Drug Alcohol Abus. 1977;4:543\u201353.","journal-title":"Am J Drug Alcohol Abus"},{"key":"94_CR45","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jsat.2012.08.003","volume":"44","author":"CL Huang","year":"2013","unstructured":"Huang CL, Lee CW. Factors associated with mortality among heroin users after seeking treatment with methadone: a population-based cohort study in Taiwan. J Subst Abus Treat. 2013;44:295\u2013300.","journal-title":"J Subst Abus Treat"},{"key":"94_CR46","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0376-8716(01)00131-4","volume":"64","author":"D Risser","year":"2001","unstructured":"Risser D, Honigschnabl S, Stichenwirth M, Pfudl S, Sebald D, Kaff A, et al. Mortality of opiate users in Vienna, Austria. Drug Alcohol Depend. 2001;64:251\u20136.","journal-title":"Drug Alcohol Depend"},{"key":"94_CR47","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1370\/afm.2098","volume":"15","author":"J Dupouy","year":"2017","unstructured":"Dupouy J, Palmaro A, Fatseas M, Auriacombe M, Micallef J, Oustric S, et al. Mortality associated with time in and out of buprenorphine treatment in french office-based general practice: a 7-year cohort study. Ann Fam Med. 2017;15:355\u20138.","journal-title":"Ann Fam Med"},{"key":"94_CR48","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.3109\/10826089809059352","volume":"33","author":"A Fugelstad","year":"1998","unstructured":"Fugelstad A, Agren G, Romelsjo A. Changes in mortality, arrests, and hospitalizations in nonvoluntarily treated heroin addicts in relation to methadone treatment. Subst Use Misuse. 1998;33:2803\u201317.","journal-title":"Subst Use Misuse"},{"key":"94_CR49","first-page":"444","volume":"67","author":"PW Appel","year":"2000","unstructured":"Appel PW, Joseph H, Richman BL. Causes and rates of death among methadone maintenance patients before and after the onset of the HIV\/AIDS epidemic. Mt Sinai J Med. 2000;67:444\u201351.","journal-title":"Mt Sinai J Med"},{"key":"94_CR50","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/oxfordjournals.aje.a112012","volume":"100","author":"FR Gearing","year":"1974","unstructured":"Gearing FR, Schweitzer MD. An epidemiologic evaluation of long-term methadone maintenance treatment for heroin addiction. Am J Epidemiol. 1974;100:101\u201312.","journal-title":"Am J Epidemiol"},{"key":"94_CR51","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.drugalcdep.2017.01.013","volume":"174","author":"T Abrahamsson","year":"2017","unstructured":"Abrahamsson T, Berge J, Ojehagen A, Hakansson A. Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment: a nation-wide register-based open cohort study. Drug Alcohol Depend. 2017;174:58\u201364.","journal-title":"Drug Alcohol Depend"},{"key":"94_CR52","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1600-0447.1997.tb10147.x","volume":"96","author":"A Fugelstad","year":"1997","unstructured":"Fugelstad A, Annell A, Rajs J, Agren G. Mortality and causes and manner of death among drug addicts in Stockholm during the period 1981-1992. Acta Psychiatr Scand. 1997;96:169\u201375.","journal-title":"Acta Psychiatr Scand"},{"key":"94_CR53","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1046\/j.1360-0443.2002.00179.x","volume":"97","author":"MCA Buster","year":"2002","unstructured":"Buster MCA, van Brussel GHA, van den Brink W. An increase in overdose mortality during the first 2 weeks after entering or re-entering methadone treatment in Amsterdam. Addiction. 2002;97:993\u20131001.","journal-title":"Addiction"},{"key":"94_CR54","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1111\/j.1360-0443.2007.02025.x","volume":"102","author":"M Davoli","year":"2007","unstructured":"Davoli M, Bargagli AM, Perucci CA, Schifano P, Belleudi V, Hickman M, et al. Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study. Addiction. 2007;102:1954\u20139.","journal-title":"Addiction"},{"key":"94_CR55","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/add.13193","volume":"111","author":"M Pierce","year":"2016","unstructured":"Pierce M, Bird SM, Hickman M, Marsden J, Dunn G, Jones A. Impact of treatment for opioid dependence on fatal drug-related poisoning: a national cohort study in England. Addiction. 2016;111:298\u2013308.","journal-title":"Addiction"},{"key":"94_CR56","doi-asserted-by":"publisher","first-page":"b2225","DOI":"10.1136\/bmj.b2225","volume":"338","author":"C McCowan","year":"2009","unstructured":"McCowan C, Kidd B, Fahey T. Factors associated with mortality in Scottish patients receiving methadone in primary care: retrospective cohort study. BMJ. 2009;338:b2225.","journal-title":"BMJ"},{"key":"94_CR57","doi-asserted-by":"crossref","unstructured":"Gowing L, Farrell MF, Bornemann R, Sullivan LE, Ali R. Oral substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev. 2011;2:CD004145.","DOI":"10.1002\/14651858.CD004145.pub4"},{"key":"94_CR58","doi-asserted-by":"publisher","first-page":"c3172","DOI":"10.1136\/bmj.c3172","volume":"341","author":"J Kimber","year":"2010","unstructured":"Kimber J, Copeland L, Hickman M, Macleod J, McKenzie J, De Angelis D, et al. Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment. BMJ. 2010;341:c3172.","journal-title":"BMJ"},{"key":"94_CR59","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.forsciint.2015.08.017","volume":"257","author":"C Vignali","year":"2015","unstructured":"Vignali C, Stramesi C, Morini L, Pozzi F, Groppi A. Methadone-related deaths: a ten year overview. Forensic Sci Int. 2015;257:172\u20136.","journal-title":"Forensic Sci Int"},{"key":"94_CR60","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.drugalcdep.2015.03.026","volume":"152","author":"CM Vajdic","year":"2015","unstructured":"Vajdic CM, Marashi Pour S, Olivier J, Swart A, O\u2019Connell DL, Falster MO, et al. The impact of blood-borne viruses on cause-specific mortality among opioid-dependent people: an Australian population-based cohort study. Drug Alcohol Depend. 2015;152:264\u201371.","journal-title":"Drug Alcohol Depend"},{"key":"94_CR61","doi-asserted-by":"publisher","first-page":"e004666","DOI":"10.1136\/bmjopen-2013-004666","volume":"4","author":"S Larney","year":"2014","unstructured":"Larney S, Gisev N, Farrell M, Dobbins T, Burns L, Gibson A, et al. Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study. BMJ Open. 2014;4:e004666.","journal-title":"BMJ Open"},{"key":"94_CR62","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/add.13779","volume":"112","author":"J Marsden","year":"2017","unstructured":"Marsden J, Stillwell G, Jones H, Cooper A, Eastwood B, Farrell M, et al. Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England. Addiction. 2017;112:1408\u201318.","journal-title":"Addiction"},{"key":"94_CR63","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S0140-6736(14)62338-2","volume":"386","author":"JD Rich","year":"2015","unstructured":"Rich JD, McKenzie M, Larney S, Wong JB, Tran L, Clarke J, et al. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial. Lancet. 2015;386:350\u20139.","journal-title":"Lancet"},{"key":"94_CR64","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1111\/add.12536","volume":"109","author":"L Degenhardt","year":"2014","unstructured":"Degenhardt L, Larney S, Kimber J, Gisev N, Farrell M, Dobbins T, et al. The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study. Addiction. 2014;109:1306\u201317.","journal-title":"Addiction"},{"key":"94_CR65","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/S0140-6736(10)60232-2","volume":"375","author":"BM Mathers","year":"2010","unstructured":"Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010;375:1014\u201328.","journal-title":"Lancet"},{"key":"94_CR66","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1111\/j.1360-0443.2012.03910.x","volume":"107","author":"E Kelty","year":"2012","unstructured":"Kelty E, Hulse G. Examination of mortality rates in a retrospective cohort of patients treated with oral or implant naltrexone for problematic opiate use. Addiction. 2012;107:1817\u201324.","journal-title":"Addiction"},{"key":"94_CR67","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0140-6736(17)32812-X","volume":"391","author":"JD Lee","year":"2017","unstructured":"Lee JD, Nunes EV, Novo P, Bachrach K, Bailey GL, Bhatt S, et al. Comparative effectiveness of extended-release naltrexone versus buprenorphine\u2013naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial. Lancet. 2017;391:309\u201318.","journal-title":"Lancet"},{"key":"94_CR68","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2165\/00002018-200022030-00002","volume":"22","author":"J Bell","year":"2000","unstructured":"Bell J, Zador D. A risk-benefit analysis of methadone maintenance treatment. Drug Saf. 2000;22:179\u201390.","journal-title":"Drug Saf"},{"key":"94_CR69","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.drugalcdep.2008.01.015","volume":"95","author":"HU Wittchen","year":"2008","unstructured":"Wittchen HU, Apelt SM, Soyka M, Gastpar M, Backmund M, Golz J, et al. Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: a naturalistic study in 2694 patients. Drug Alcohol Depend. 2008;95:245\u201357.","journal-title":"Drug Alcohol Depend"},{"key":"94_CR70","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/add.12834","volume":"110","author":"L Burns","year":"2015","unstructured":"Burns L, Gisev N, Larney S, Dobbins T, Gibson A, Kimber J, et al. A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia. Addiction. 2015;110:646\u201355.","journal-title":"Addiction"},{"key":"94_CR71","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2105\/AJPH.2012.301049","volume":"103","author":"RP Schwartz","year":"2013","unstructured":"Schwartz RP, Gryczynski J, O\u2019Grady KE, Sharfstein JM, Warren G, Olsen Y, et al. Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009. Am J Public Health. 2013;103:917\u201322.","journal-title":"Am J Public Health"},{"key":"94_CR72","doi-asserted-by":"publisher","first-page":"e1208","DOI":"10.1016\/S2214-109X(17)30373-X","volume":"5","author":"S Larney","year":"2017","unstructured":"Larney S, Peacock A, Leung J, Colledge S, Hickman M, Vickerman P, et al. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review. Lancet Glob Health. 2017;5:e1208\u201320.","journal-title":"Lancet Glob Health"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41380-018-0094-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41380-018-0094-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41380-018-0094-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T16:58:21Z","timestamp":1684601901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-018-0094-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,22]]},"references-count":72,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["94"],"URL":"https:\/\/doi.org\/10.1038\/s41380-018-0094-5","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,22]]},"assertion":[{"value":"30 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"In the past three years, LD and MF have received investigator-initiated untied educational grants for studies of opioid medications in Australia from Indivior, Mundipharma and Seqirus.The\u00a0other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}